AL MPJE key terms

The state agency that licenses pharmacists, interns, and pharmacies in Alabama, adopts rules that carry out the Pharmacy Practice Act, investigates complaints, and imposes discipline on licensees who violate the law.

Alabama's statute that establishes who may practice pharmacy, what activities fall within pharmacy practice, how pharmacies are permitted, and what conduct leads to discipline. Board rules add detail and must be consistent with it.

A regulation adopted by the Alabama Board of Pharmacy under statutory authority. Rules go through notice-and-comment rulemaking, have the force of law, and fill in operational detail such as records, labeling, and equipment standards.

A route to Alabama licensure for a pharmacist already licensed in another state; the applicant must meet Alabama's requirements, transfer or otherwise satisfy examination requirements, and document good standing and lawful practice.

A credential the Board issues to a pharmacy student or graduate who is gaining the supervised practical experience required for licensure; interns practice only under a preceptor's supervision and within limits set by rule.

The license the Board issues to a specific pharmacy location. It authorizes the holder to dispense prescription drugs at that address and depends on having a pharmacist-in-charge, compliant space, equipment, and records.

An Alabama-authorized written agreement between a pharmacist and a prescriber that lets the pharmacist manage specified drug therapy, such as adjusting doses or ordering laboratory tests, for patients covered by the agreement.

A drug that federal or state law requires to be dispensed only on a prescription because it is not safe for use without professional supervision. Alabama restricts who may sell or dispense it and how it is ordered.

A lawful prescriber's instruction for a specific patient that authorizes dispensing of a drug, including the drug, strength, quantity, directions, and refills. It must be issued in a manner the Board permits, such as written, oral, or electronic.

The duty of the pharmacist or intern to personally ask each patient or caregiver whether they want advice about the medication and to provide it privately when requested; simply handing over a leaflet does not satisfy the duty.

The minimum information Alabama requires on a dispensed container, such as pharmacy name and address, prescription number, date, patient and prescriber names, directions, drug name and strength, and quantity, plus any required warnings.

The number of times a prescription may be repeated as authorized by the prescriber. Refills must be recorded, may not exceed the authorized number or any legal time limit, and Schedule II prescriptions cannot be refilled.

Moving prescription information from one pharmacy to another at the patient's request so it can be dispensed there. Federal rules limit controlled substance transfers, and Alabama sets procedures to keep records complete and void the original.

Dispensing a therapeutically equivalent, usually less expensive product in place of the prescribed brand. State law permits it unless the prescriber directs otherwise, and the pharmacist must record what was actually dispensed.

Federal standards requiring most oral prescription drugs to be dispensed in packaging that is difficult for children to open. Patients may request noncomplying packaging, and the pharmacy must document that request.

The five federal classifications, I through V, that rank drugs by abuse potential and accepted medical use. The schedule controls whether a drug may be prescribed, how many refills are allowed, and recordkeeping requirements.

Federal authorization a practitioner or business must hold before handling controlled substances. It is separate from state licensure, must be renewed periodically, and is tied to specific schedules and a specific location.

An Alabama certificate that practitioners must hold, in addition to a DEA registration, before they may prescribe, dispense, or administer controlled substances in the state.

Alabama's electronic database that collects dispensed controlled substance prescriptions. Dispensers must report each fill promptly, and authorized prescribers and pharmacists may review a patient's history before making prescribing or dispensing decisions.

A telephone order for a Schedule II drug allowed only in a genuine emergency. Federal rules limit the quantity to the emergency period and require the prescriber to deliver a written prescription within seven days.

Dispensing less than the full quantity of a Schedule II prescription, allowed in limited situations such as insufficient stock or a patient in a long-term care facility, with the balance supplied within federal time limits.

The order form, now often electronic through CSOS, that a registrant must use to buy or transfer Schedule I or II controlled substances. It documents the transaction and must be kept and reconciled with inventory.

A complete count of all controlled substances on hand, taken every two years on the registrant's chosen date and kept with required records. It is a snapshot against which later inventories and transactions are measured.

The report a registrant files with DEA when controlled substances are stolen or lost in significant amounts. It describes what happened and supports investigation, and the state board may require separate notice.

A DEA-registered entity that receives expired or unwanted controlled substances from pharmacies and oversees their destruction or return, keeping them out of the regular trash and out of the usual supply chain.

FDA's ranking of recall seriousness: Class I for products likely to cause serious harm, Class II for temporary or reversible harm, and Class III for violations unlikely to cause harm. Pharmacies must act on recalls promptly.

The supply-chain documentation that must accompany prescription drug products as they move between trading partners, showing who handled the product, key dates, and that it was not diverted.

State authorization required for a business that buys prescription drugs from manufacturers and sells them to pharmacies or other distributors. Alabama requires licensure and compliance with pedigree, storage, and recordkeeping rules.

The date after which a compounded preparation may no longer be used, based on its ingredients, container, storage, and water content. It is assigned by the compounder and may be shorter than the manufacturer's expiration date.

The national standard for sterile compounding that sets requirements for clean rooms, environmental monitoring, personnel training, and verification of finished preparations. Alabama's compounding rules look to these standards for sterile preparations.

The detailed written formula and procedure a pharmacy follows when it prepares a compounded product repeatedly. It records ingredients, equipment, and steps and is used to create the patient-specific compounding record.

The training and credentials, such as immunization and CPR training, a pharmacist must complete before administering vaccines. Alabama requires the pharmacist to practice under an approved protocol and to report doses as required.

A written authorization that lets a pharmacist provide a drug or vaccine to patients meeting set criteria without an individual prescription. It names the drug, the eligible patients, and the documentation required.

A statewide authorization that lets Alabama pharmacists dispense naloxone, an opioid overdose antidote, to people at risk or to family members without a patient-specific prescription, with counseling on how to use it.

The state's public health agency, which runs disease prevention and immunization programs, issues public health orders, and works with pharmacies on reporting, vaccine distribution, and emergency response.

The pharmacist the Board holds responsible for day-to-day compliance at a permitted pharmacy, including staffing, records, security, and quality programs. A pharmacy cannot operate without one.

A pharmacy's written system for reporting, reviewing, and learning from medication errors and near misses so that processes can be changed to reduce future harm. Records of the review are kept and protected.

The review a pharmacist performs before dispensing, checking for therapeutic duplication, interactions, allergies, incorrect doses, and overuse to catch problems while they can still be prevented.